Skip to main content

This job has expired

You will need to login before you can apply for a job.

Scientist, Formulation Development (CONTRACT)

Employer
Sangamo Therapeutics, Inc.
Location
Brisbane, CA
Start date
Jul 18, 2021

View more

Discipline
Science/R&D, Biotechnology
Required Education
Bachelors Degree
Position Type
Contract
Hotbed
Biotech Bay

Job Details

Manager: Senior Director, Formulations
Department: Technical Operations – Cell & Gene Therapy, Formulations & Fill/Finish
Location: Brisbane, CA

Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. Using its deep scientific expertise and proprietary zinc finger genome engineering technology, Sangamo is working to create genomic cures for patients suffering from severe genetic diseases for which today’s medicines can only treat symptoms. At Sangamo, we are passionate about transforming lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the needs of patients with commitment and compassion. Along with our commitment to science and to our patients, we also endeavor to create an inclusive environment that promotes and values diversity. Sangamo is a company where individuals can flourish, grow and develop their expertise.

We are seeking top talent to join our mission. Let’s build a better future together.


JOB SUMMARY:   
Sangamo Therapeutics is seeking a highly motivated individual to contribute to the development of best-in-class viral vector for CNS indications. The successful candidate will be responsible for the formulation and DP process development of Sangamo’s internal and partnered programs. The scientist will be responsible for designing and executing formulation screen, analyze and interpret data to support Tox, Phase I/II formulation selection as well as author and review technical reports and sections for regulatory submissions. The scientist will operate in a cross-functional environment and collaborate successfully within and outside Technical Operations to drive product and process excellence.


ESSENTIAL FUNCTIONS: 

  • Plan, design and execute univariate/multivariate studies to develop robust and manufacturable formulations and DP processes
  • Process data, compile results, report and communicate study findings
  • Develop and implement novel biochemical and biophysical methods suitable for cell and gene therapy product characterization.
  • Lead and/or participate in CMC/project teams for functional representation as well as support teams’ objectives and project deliverables.
  • Author and review technical protocols and reports to document study findings in support of Investigational New Drug (IND), IND amendments, BLA, as well as global marketing application submissions.
  • Partner with internal/external manufacturing and quality for process improvement, transfers, compilation and review of batch records, master production records and technical support to resolve investigations, deviations, corrective/preventative actions.
  • Excellent communication and interpersonal skills, with proven ability to work effectively in cross-functional teams to meet project milestone and timelines.


EDUCATION, EXPERIENCE AND SKILLS REQUIREMENTS:

  • BS/MS/PhD degree in biochemistry, pharmaceutical sciences, biochemical engineering, or related discipline.
  • 1-3 years of laboratory experience in biotechnology or pharmaceutical industry.
  • Experience with biologics formulation development, DP process design and manufacturing Fill/Finish is highly desirable, however, academic experience related to cell culture, analytical chemistry, viral vectors, or gene therapy will be considered.
  • Proficiency with applying chromatographic (HPLC, UPLC, column chromatography) methods, capillary electrophoresis and biophysical techniques (UV-vis, DLS, CD, FTIR, DSC, AUC, Fluorescence, particle analysis, etc.) for formulation characterization
  • AAV gene therapy, Cell Therapy & Gene Editing experience is desirable
  • Sound understanding of statistical methods and data analysis tools (e.g. JMP).
  • Team player, with good interpersonal and organizational skills.

 

Sangamo is an equal opportunity employer
The above reflects management’s definition of essential functions for this position but does not restrict the tasks that may be assigned. The above duties are representative only; management may assign or reassign duties and responsibilities to this position at any time.

Note to External Recruiters: Please understand that we do not accept unsolicited resumes from any source other than from the candidates themselves. Any agency or independent recruiter must have a signed copy of our agency agreement before presenting candidates. Submission of unsolicited resumes without our signed agreement will not create any implied obligation on our part.

If you wish to be considered for the presentation of candidates, please contact us through Recruiting@sangamo.com. Attach your contact information, your area of specialty, and any marketing information you wish to provide. Someone from the Talent Acquisition Department will contact you directly if there is a business need for your services.

#LI-KO1





 


Company

Sangamo Therapeutics is a genomic medicine company building value with cutting-edge work across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. At Sangamo, we are passionate in developing genomic medicines to transform the lives of patients with serious diseases. We transform lives by building a robust, sustainable, differentiated, innovative, and high value genomic medicine pipeline that addresses patients with life-limiting conditions. Sangamo takes pride in being the first to edit endogenous human genes, first to treat patients with gene edited T cells, and first to treat patients with in vivo genome editing. Our top priority is to meet the needs of patients with commitment and compassion. Along with our commitment to science and to our patients, we also endeavor to create an inclusive environment that promotes and values diversity. Sangamo is a company where individuals can flourish, grow and develop their expertise.

We are seeking top talent to join our mission. Let’s build a better future together.

Stock Symbol: SGMO

TwitterFacebook

 

Company info
Website
Phone
(510) 970-6000
Location
7000 Marina Blvd
Brisbane
CA
94005
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert